Brief: Vaxart Announces Publication In Vaccines Of Preclinical Data
28/08/2024 13:05
Aug 28 (Reuters) - Vaxart Inc VXRT.O :
* VAXART ANNOUNCES PUBLICATION IN VACCINES OF PRECLINICAL
DATA
SUPPORTING THE POTENTIAL OF ITS MUCOSAL VACCINE TECHNOLOGY
PLATFORM IN ENABLING THERAPEUTIC VACCINATION FOR HPV-RELATED
CERVICAL DYSPLASIA
* VAXART- CO'S HPV VACCINE CONSTRUCTS CAN STIMULATE POTENT
IMMUNE
RESPONSE AGAINST HPV16 PROTEINS E6 & E7
Source text for Eikon: ID:nGNX9jLNpS
Further company coverage: VXRT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts